(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BRAINCORE THERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BRAINCORE THERAPY

ST13

US500000085141329

Class

41

Filing

85141329

Registration

4088770

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/29/2022

Trademark type

Combined

Nice classes

41

Filing date

09/29/2010

Registration date

01/17/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/29/2022

Last transaction

12/29/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/31/2010

First use in commerce

10/31/2010

Drawing code

3

Owner type

16

Owner location

Bluffton, SC, US

Examiner

MICHOS, JOHN E

Law office

L50

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the words "BRAINCORE THERAPY" followed by a crescent moon shape.

Holders and representatives

Holders

BrainCore Systems, LLC
BrainCore Systems, LLC

Representatives

Ashley B. Summer Nelson Mullins Riley & Scarborough LLP

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Training services in the field of neurofeedback

Publications

History of USPTO decisions and trademark events.

38 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/29/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/29/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/29/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

12/27/2022

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

06/27/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/25/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

01/18/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/17/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/26/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/26/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/26/2018

E815

TEAS SECTION 8 & 15 RECEIVED

07/17/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/17/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

01/17/2012

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/13/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

12/12/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/07/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/22/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/21/2011

IUAF

USE AMENDMENT FILED

11/15/2011

EISU

TEAS STATEMENT OF USE RECEIVED

11/15/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/17/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2011

PUBO

PUBLISHED FOR OPPOSITION

03/22/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/17/2011

ALIE

ASSIGNED TO LIE

02/11/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/19/2011

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

01/14/2011

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/14/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

01/14/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/14/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

01/14/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/14/2011

DOCK

ASSIGNED TO EXAMINER

01/07/2011

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

10/05/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2010

NWAP

NEW APPLICATION ENTERED

10/02/2010

Continuous trademark protection

Get notified about every new filing that threatens BRAINCORE THERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.